Skip to content

Combination of Taliderm® and Vacuum-assisted Closure (VAC) for Treatment of Pressure Ulcers

Combination of Taliderm® and VAC for Treatment of Pressure Ulcers - a Pilot Study

Status
Terminated
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02237287
Enrollment
24
Registered
2014-09-11
Start date
2011-02-28
Completion date
2012-08-31
Last updated
2015-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pressure Ulcer, Wounds

Brief summary

Background: The wound healing promoting effect of negative wound pressure therapies (NWPT) takes place at the wound foam interface. Implementation of bioactive substances at this site represents a major research area for the development of future NWPT devices. Methods: Wound healing kinetics of pressure ulcers treated by vacuum assisted closure devices with or without the implementation of a thin interface of poly-N-acetyl glucosamine nanofibers (sNAG) was studied in a prospective randomized clinical trial.

Interventions

OTHERwound dressing with VAC and sNAG without antiaggregation
PROCEDUREwound dressing with VAC
DRUGwound dressing with VAC and sNAG under Antiaggregation

Sponsors

Marine Polymer Technologies, Inc.
CollaboratorINDUSTRY
University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ischial/sacral Pressure ulcer between 4 and 15cm diameter * Greater than or equal to 18 years of age * Ability to obtain informed consent

Exclusion criteria

* Connective tissue disorders * Immunosuppression, Hemodialysis, Steroids * Pregnancy * Sepsis

Design outcomes

Primary

MeasureTime frame
Number of Participants with Adverse Events as a Measure of Safety and Tolerabilityup to 1 year
Wound surface area increase, respectively decrease as a measure of the effect of the studied devices on pressure ulcer healingup to 1 year

Secondary

MeasureTime frameDescription
Wound Healing characteristicsup to 1 yearEvaluation of granulation tissue formation in study groups

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026